IMD Medical Group is a clinical research site located in Los Angeles, California, United States 90020.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
IMD Medical Group has participated in 6 clinical trials.
Therapeutic areas: Heterozygous Familial Hypercholesterolemia, Chronic Pain, Osteoarthritis, Hip.
Sponsors: Pfizer, Yiling Pharmaceutical Inc., Pfizer's Upjohn has merged with Mylan to form Viatris Inc..
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
IMD Medical Group has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
IMD Medical Group has 6 clinical trials on record. Their work covers Heterozygous Familial Hypercholesterolemia, Chronic Pain, Osteoarthritis, Hip.
Yes — IMD Medical Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.